Concepedia

An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in germline BRCA -mutated ( gBRCA m) platinum-sensitive relapsed (PSR) ovarian cancer (OC)

Yvette Drew, Maja J.A. de Jonge, Sook Hee Hong, Y.H. Park, Anita Wolfer, Jennifer R. Brown, Michelle Ferguson, Martin Gore, Ricardo H. Álvarez, Christopher Gresty,

Gynecologic Oncology · 2018 · 130 citations · 0 references

DOI

Concepts